CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
4.800
-0.300 (-5.88%)
At close: Feb 11, 2026, 4:00 PM EST
4.750
-0.050 (-1.04%)
After-hours: Feb 11, 2026, 4:33 PM EST
CervoMed Market Cap
CervoMed has a market cap or net worth of $44.37 million as of February 11, 2026. Its market cap has increased by 142.13% in one year.
Market Cap
44.37M
Enterprise Value
19.89M
1-Year Change
142.13%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has increased from $43.26M to $44.37M, an increase of 2.55%. That is a compound annual growth rate of 1.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 47.19M | -35.44% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 54.66M |
| Cingulate | 54.48M |
| Tevogen Bio Holdings | 52.40M |
| Instil Bio | 52.29M |
| Nutriband | 51.78M |
| MiNK Therapeutics | 51.68M |
| Q32 Bio | 51.43M |
| Acrivon Therapeutics | 51.12M |